Global Pharmaceuticals & Biotech Undervalued based on future growth

Rallybio

Market Cap: US$90.2m

A clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Hyphens Pharma International

Market Cap: S$112.8m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

Labiana Health

Market Cap: €54.4m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

DreamCIS

Market Cap: ₩88.1b

Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.

Actinium Pharmaceuticals

Market Cap: US$32.7m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.